Back to News

Remote Monitoring Solution Now Available
for All Clinical Research Sites

³Ô¹Ï±¬ÁÏ SiteVault allows sites to share and collaborate remotely with study monitors
for source document review and verification

³Ô¹Ï±¬ÁÏ supporting industrywide drive to accelerate study execution
and improve trial quality across sites, sponsors, and CROs

PLEASANTON, CA ¡ª April 2, 2020 - ³Ô¹Ï±¬ÁÏ Systems (NYSE:VEEV) today announced new remote monitoring capabilities in ³Ô¹Ï±¬ÁÏ SiteVault for source document review and verification in clinical trials. ³Ô¹Ï±¬ÁÏ SiteVault gives research sites a free eRegulatory application to efficiently manage study documentation and now with remote monitoring, allows study monitors to access, review, and collaborate on content online. Sites can centralize monitoring and communication with sponsors and CROs using a free system that is compliant with 21 CFR Part 11 and HIPAA requirements.

¡°Remote monitoring supports the immediate need for sites and study monitors to continue working together while onsite visits have largely stopped,¡± said Bree Burks, RN, MSN, vice president of site strategy at ³Ô¹Ï±¬ÁÏ and a former clinical research director. ¡°³Ô¹Ï±¬ÁÏ SiteVault gives sites access to remote monitoring capabilities, at no cost, so they can keep running studies and treating patients.¡±

SiteVault allows sites, sponsors, and CROs to remotely manage and track the workflow and downstream processes for source document review and verification. Sites and study monitors can easily view, comment, and respond to questions in a single, centralized system. Reporting, dashboards, and automatic notifications enable stakeholders to organize their tasks, get complete visibility into documents, and prioritize activities for immediate action.

Remote monitoring is available today in ³Ô¹Ï±¬ÁÏ SiteVault. See a demo and learn more at .

What Sites are Saying About Remote Monitoring in ³Ô¹Ï±¬ÁÏ SiteVault

¡°I¡¯m excited by what ³Ô¹Ï±¬ÁÏ is doing to help the industry,¡± said Trisha Locke, chief executive officer at Keystone Research. ¡°As a high-volume ophthalmology site, we needed a solution that allows sponsors to access our study data. ³Ô¹Ï±¬ÁÏ SiteVault gives us a free, compliant solution to manage regulatory documents and provide remote access to source information.¡±

¡°COVID-19 has impacted our ability to see patients and monitors onsite,¡± said William Chrvala, CCRC, managing director of Mid Hudson Medical Research, PLLC. ¡°³Ô¹Ï±¬ÁÏ SiteVault helps us quickly respond to changing business practices and focus on what matters most ¨C our study participants.¡±

¡°The ability to monitor studies remotely improves data quality and real-time responsiveness,¡± said Amanda Wright, vice president of partnership development at Javara. ¡°Solutions like ³Ô¹Ï±¬ÁÏ SiteVault can help sites improve engagement with sponsors and CROs.¡±

About ³Ô¹Ï±¬ÁÏ SiteVault

³Ô¹Ï±¬ÁÏ SiteVault reduces the administrative burden of managing regulatory documents and processes for all trials with capabilities such as remote monitoring, electronic signatures, certified copy workflows, and reporting. For more information about ³Ô¹Ï±¬ÁÏ SiteVault or to sign-up, visit .

Additional Information
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 850 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-K for the period ended January 31, 2020. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.

###

Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com

Deivis Mercado
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com